BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DUVAX readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of DUVAX\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07142278-679@assetmemo.bio
DTSTAMP:20261121T005422Z
DTSTART;VALUE=DATE:20270401
DTEND;VALUE=DATE:20270402
SUMMARY:DUVAX: Phase 1 readout est. (NCT07142278)
DESCRIPTION:DUVAX\, phase 1\, Alzheimer's Disease.\nStudy: DUVAX: A Phase 1
  Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau\nEstimated prima
 ry completion: 1 April 2027. This is a ClinicalTrials.gov estimate\, not a
  confirmed readout date\, and it can move.\nDrug page: https://assetmemo.b
 io/drug/duvax#upcoming-events\nRegistry record: https://clinicaltrials.gov
 /study/NCT07142278
URL:https://assetmemo.bio/drug/duvax#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
